Anti-Suicide Drugs Market

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.

Anti-Suicide Drugs Market contains market size and forecasts of Anti-Suicide Drugs in global, including the following market information:

Global Anti-Suicide Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-Suicide Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Anti-Suicide Drugs companies in 2021 (%)

The global Anti-Suicide Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anti-Depressants and Anti-Anxiety Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Suicide Drugs include Pfizer, Inc, AstraZeneca Plc, Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc, H. Lundbeck A/S, NeuroRx, Inc and Johnson & Johnson. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Anti-Suicide Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Suicide Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Suicide Drugs Market Segment Percentages, by Type, 2021 (%)

• Anti-Depressants and Anti-Anxiety Drugs
• Anti-Psychotic Drugs
• NMDA Antagonist
• Antibiotic Analog

Global Anti-Suicide Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Suicide Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Retail Pharmacies
• Online Pharmacies

Global Anti-Suicide Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Suicide Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Anti-Suicide Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Anti-Suicide Drugs revenues share in global market, 2021 (%)
• Key companies Anti-Suicide Drugs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Anti-Suicide Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer, Inc
• AstraZeneca Plc
• Eli Lilly and Company
• Allergan Plc
• GlaxoSmithKline Plc
• Merck & Co., Inc
• H. Lundbeck A/S
• NeuroRx, Inc
• Johnson & Johnson